
TY  - JOUR
TI  - American Society of Transplant Surgeons: 18th Annual State of the Art Winter Symposium
JO  - American Journal of Transplantation
VL  - 18
IS  - S2
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.14572
DO  - doi:10.1111/ajt.14572
SP  - 13
EP  - 99
PY  - 2018
ER  - 

TY  - JOUR
TI  - Scientific Section
JO  - Transfusion
VL  - 50
IS  - s2
SN  - 0041-1132
UR  - https://doi.org/10.1111/j.1537-2995.2010.02833_1.x
DO  - doi:10.1111/j.1537-2995.2010.02833_1.x
SP  - 1A
EP  - 231A
PY  - 2010
ER  - 

TY  - JOUR
AU  - Gey, A.
AU  - Tadie, J.-M.
AU  - Caumont-Prim, A.
AU  - Hauw-Berlemont, C.
AU  - Cynober, L.
AU  - Fagon, J.-Y.
AU  - Terme, M
AU  - Diehl, J.-L.
AU  - Delclaux, C.
AU  - Tartour, E.
TI  - Granulocytic myeloid-derived suppressor cells inversely correlate with plasma arginine and overall survival in critically ill patients
JO  - Clinical & Experimental Immunology
JA  - Clin Exp Immunol
VL  - 180
IS  - 2
SN  - 0009-9104
UR  - https://doi.org/10.1111/cei.12567
DO  - doi:10.1111/cei.12567
SP  - 280
EP  - 288
KW  - arginine
KW  - biomarker
KW  - critically ill patients
KW  - granulocytic myeloid-derived suppressor cells (gMDSC)
KW  - immunosuppression
PY  - 2015
AB  - Summary Critically ill patients display a state of immunosuppression that has been attributed in part to decreased plasma arginine concentrations. However, we and other authors have failed to demonstrate a clinical benefit of L-arginine supplementation. We hypothesize that, in these critically ill patients, these low plasma arginine levels may be secondary to the presence of granulocytic myeloid-derived suppressor cells (gMDSC), which express arginase known to convert arginine into nitric oxide (NO) and citrulline. Indeed, in a series of 28 non-surgical critically ill patients, we showed a dramatic increase in gMDSC compared to healthy subjects (P?=?0·0002). A significant inverse correlation was observed between arginine levels and gMDSC (P?=?0·01). As expected, gMDSC expressed arginase preferentially in these patients. Patients with high gMDSC levels on admission to the medical intensive care unit (MICU) presented an increased risk of death at day 7 after admission (P?=?0·02). In contrast, neither plasma arginine levels, monocytic MDSC levels nor neutrophil levels were associated with overall survival at day 7. No relationship was found between body mass index (BMI) or simplified acute physiology score (SAPS) score, sequential organ failure assessment (SOFA) score or gMDSC levels, eliminating a possible bias concerning the direct prognostic role of these cells. As gMDSC exert their immunosuppressive activity via multiple mechanisms [production of prostaglandin E2 (PGE2), interleukin (IL)-10, arginase, etc.], it may be more relevant to target these cells, rather than simply supplementing with L-arginine to improve immunosuppression and its clinical consequences observed in critically ill patients.
ER  - 

TY  - JOUR
TI  - Poster Presentation Abstracts
JO  - International Journal of Rheumatic Diseases
JA  - Int J Rheum Dis
VL  - 21
IS  - S1
SN  - 1756-1841
UR  - https://doi.org/10.1111/1756-185X.13361
DO  - doi:10.1111/1756-185X.13361
SP  - 23
EP  - 236
PY  - 2018
ER  - 

TY  - JOUR
TI  - ASGBI abstracts 2010
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 97
IS  - S2
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.7051
DO  - doi:10.1002/bjs.7051
SP  - 76
EP  - 202
PY  - 2010
ER  - 

C7  - pp. 58-146
TI  - Ferrets
SN  - 9780813818313
UR  - https://doi.org/10.1002/9781118969601.ch2
DO  - doi:10.1002/9781118969601.ch2
SP  - 58-146
KW  - adrenal gland disease
KW  - cardiovascular conditions
KW  - endocrine conditions
KW  - eosinophilic gastroenteritis
KW  - ferrets
KW  - gastrointestinal conditions
KW  - musculoskeletal conditions
KW  - nonspecific lymphoplasmacytic hepatitis
KW  - respiratory conditions
PY  - 2010
AB  - Summary Ferrets are commonly used as an animal model for influenza virus research, as well as other disease conditions, such as Helicobacter-induced gastropathy. Eosinophilic gastroenteritis is a distinct idiopathic inflammatory condition of young adult ferrets. Affected animals may present with vomiting, diarrhea, and lethargy, and a marked eosinophilia may be noted during routine hematologic evaluation. Hematologic changes may include nonregenerative anemia, hypergammaglobulinemia, hypoalbuminemia, and thrombocytopenia. Differential diagnoses for hypergammaglobulinemia and/or abdominal masses include Aleutian disease, lymphosarcoma, chronic infection (e.g., proliferative colitis, helicobacteriosis), idiopathic splenomegaly, multiple myeloma, other neoplasms, and inflammatory bowel disease. Hepatic coccidiosis and toxoplasmosis are seen sporadically in ferrets. Similarly, systemic viral disease caused by infection with canine distemper virus, influenza virus, Aleutian disease (a parvovirus infection), and coronavirus may induce foci of hepatic necrosis and inflammation. Nonspecific lymphoplasmacytic hepatitis may be seen with moderate regularity in surgical biopsies or tissue sections from adult ferrets as an extension of gastrointestinal inflammatory conditions.
ER  - 

TY  - JOUR
TI  - Scientific Section
JO  - Transfusion
VL  - 49
IS  - s3
SN  - 9780813818313
UR  - https://doi.org/10.1111/j.1537-2995.2009.02366.x
DO  - doi:10.1111/j.1537-2995.2009.02366.x
SP  - 1A
EP  - 305A
PY  - 2009
ER  - 

TY  - JOUR
TI  - Posters
JO  - Transplant International
JA  - Transpl Int
VL  - 26
IS  - s2
SN  - 9780813818313
UR  - https://doi.org/10.1111/tri.12214
DO  - doi:10.1111/tri.12214
SP  - 185
EP  - 339
PY  - 2013
ER  - 

TY  - JOUR
TI  - Posters
JO  - Journal of Thrombosis and Haemostasis
VL  - 7
IS  - s2
SN  - 9780813818313
UR  - https://doi.org/10.1111/j.1538-7836.2009.03473_2.x
DO  - doi:10.1111/j.1538-7836.2009.03473_2.x
SP  - 317
EP  - 1168
PY  - 2009
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Haemophilia
JA  - Haemophilia
VL  - 20
IS  - s3
SN  - 9780813818313
UR  - https://doi.org/10.1111/hae.12400
DO  - doi:10.1111/hae.12400
SP  - 1
EP  - 186
PY  - 2014
ER  - 

TY  - JOUR
TI  - Posters
JO  - Journal of the European Academy of Dermatology and Venereology
VL  - 11
IS  - s2
SN  - 9780813818313
UR  - https://doi.org/10.1111/j.1468-3083.1998.tb00997.x
DO  - doi:10.1111/j.1468-3083.1998.tb00997.x
SP  - S187
EP  - S326
PY  - 1998
ER  - 

TY  - JOUR
TI  - Abstracts—Posters
JO  - Alcoholism: Clinical and Experimental Research
JA  - Alcohol Clin Exp Res
VL  - 40
IS  - S1
SN  - 9780813818313
UR  - https://doi.org/10.1111/acer.13084
DO  - doi:10.1111/acer.13084
SP  - 16A
EP  - 247A
PY  - 2016
ER  - 

TY  - JOUR
TI  - ASBMR 2010 Annual Meeting SU0001–SU0482
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 25
IS  - S1
SN  - 9780813818313
UR  - https://doi.org/10.1002/jbmr.5650251304
DO  - doi:10.1002/jbmr.5650251304
SP  - S225
EP  - S362
PY  - 2010
ER  - 

TY  - JOUR
TI  - Winter Meeting 2013. Joint Meeting of the Pathological Society of Great Britain & Ireland and the Dutch Pathological Society (NVVP), 8–9 January
JO  - The Journal of Pathology
JA  - J. Pathol.
VL  - 229
IS  - s1
SN  - 9780813818313
UR  - https://doi.org/10.1002/path.4190
DO  - doi:10.1002/path.4190
SP  - 1
EP  - 31
PY  - 2013
ER  - 

TY  - JOUR
TI  - Abstracts TPS
JO  - Allergy
JA  - Allergy
VL  - 73
IS  - S105
SN  - 9780813818313
UR  - https://doi.org/10.1111/all.13539
DO  - doi:10.1111/all.13539
SP  - 370
EP  - 702
PY  - 2018
ER  - 

TY  - JOUR
TI  - THE AUSTRALIAN RHEUMATOLOGY ASSOCIATION
JO  - Australian and New Zealand Journal of Medicine
VL  - 30
IS  - 4
SN  - 9780813818313
UR  - https://doi.org/10.1111/j.1445-5994.2000.tb02071.x
DO  - doi:10.1111/j.1445-5994.2000.tb02071.x
SP  - 523
EP  - 549
PY  - 2000
ER  - 

TY  - JOUR
TI  - Thursday, 28 July 2011
JO  - Journal of Thrombosis and Haemostasis
VL  - 9
IS  - s2
SN  - 9780813818313
UR  - https://doi.org/10.1111/j.1538-7836.2011.04380_4.x
DO  - doi:10.1111/j.1538-7836.2011.04380_4.x
SP  - 712
EP  - 959
PY  - 2011
ER  - 

TY  - JOUR
TI  - Monday, 6 July 1998
JO  - British Journal of Haematology
VL  - 102
IS  - 1
SN  - 9780813818313
UR  - https://doi.org/10.1111/j.1365-2141.1998.tb08995.x
DO  - doi:10.1111/j.1365-2141.1998.tb08995.x
SP  - 2
EP  - 139
PY  - 1998
ER  - 

TY  - JOUR
TI  - Absracts
JO  - Vox Sanguinis
VL  - 83
IS  - S2
SN  - 9780813818313
UR  - https://doi.org/10.1111/j.1423-0410.2002.tb05391.x
DO  - doi:10.1111/j.1423-0410.2002.tb05391.x
SP  - 1
EP  - 236
PY  - 2002
ER  - 

TY  - JOUR
AU  - Lucca, Liliana E.
AU  - Hafler, David A.
TI  - Co-inhibitory blockade while preserving tolerance: checkpoint inhibitors for glioblastoma
JO  - Immunological Reviews
JA  - Immunol Rev
VL  - 276
IS  - 1
SN  - 9780813818313
UR  - https://doi.org/10.1111/imr.12529
DO  - doi:10.1111/imr.12529
SP  - 9
EP  - 25
KW  - coinhibitory receptor
KW  - glioblastoma
KW  - T-cell exhaustion
KW  - tolerance
PY  - 2017
AB  - Summary The introduction of immunotherapy with checkpoint receptor blockade has changed the treatment of advanced cancers, at times inducing prolonged remission. Nevertheless, the success rate of the approach is variable across patients and different tumor types, and treatment is often accompanied by severe immune-related side effects, suggesting the importance of co-inhibitory pathway for both prevention of autoimmunity and failure of tumor rejection. A better understanding of how to uncouple anti-tumor activity from loss of self-tolerance is necessary to increase the therapeutic efficacy of checkpoint immunotherapy. In this review, we describe basic concepts of T-cell exhaustion that occur in cancer, highlighting the role of co-inhibitory receptors in contributing to this process while preventing immunopathology. By providing an overview of the current therapeutic success and immune-related burden of secondary effects of checkpoint immunotherapy, we illustrate the ?double-edged sword? related to interference with immune-regulatory pathways. Finally, since achieving tumor rejection while preserving self-tolerance is particularly important for the central nervous system, we analyze the case for checkpoint immunotherapy in glioblastoma, the most common adult brain tumor.
ER  - 
